|

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3

RECRUITINGN/ASponsored by Karolinska Institutet
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2022-11-01
Est. completion2025-12-31
Eligibility
Age35 Years – 79 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05426408

Summary

The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.

Eligibility

Age: 35 Years – 79 YearsHealthy volunteers accepted
Inclusion Criteria:

* a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
* age 35-80 years
* reading and writing proficiency in Swedish

Exclusion Criteria:

* Claustrofobia
* Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III)
* Asthma or severe chronic obstructive lung disease
* eGFR \< 30 ml/min
* spontaneous coronary artery dissection
* acute pulmonary embolism
* acute myocardial infarction type 2
* cardiomyopathy other than takotsubo syndrome
* a previous myocardial infarction due to CAD

Conditions2

Heart DiseaseMyocardial Infarction with Nonobstructive Coronary Arteries

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.